Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC271

Brigatinib, eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    17.5.2019
  • Application published:
    15.6.2019
  • Grant published:
    15.11.2020
  • Max expiry date:
    25.11.2033
  • Medicine name:
    Alunbrig
  • Medicine for children:
    No

Timeline

Today
17.5.2019Application
15.6.2019Publication
15.11.2020Registration
25.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1264/001-004; EU/1/18/1264/005-008; EU/1/18/1264/009-010
  • Date:
    6.12.2018
  • Foreign authorization number:
    EU/1/18/1264
  • Date:
    22.11.2018

Owner

  • Name:
    Takeda Pharmaceutical Company Limited
  • Address:
    1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka JP

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105 Reykjavík

Patent

Upload documents